Thitirat Ngaotepprutaram, Ph.D. - Publications
Affiliations: | 2013 | Pharmacology and Toxicology-Environmental Toxicology - Doctor of Philosophy | Michigan State University, East Lansing, MI |
Area:
Pharmacology, ImmunologyYear | Citation | Score | |||
---|---|---|---|---|---|
2013 | Ngaotepprutaram T, Kaplan BL, Kaminski NE. Impaired NFAT and NFκB activation are involved in suppression of CD40 ligand expression by Δ(9)-tetrahydrocannabinol in human CD4(+) T cells. Toxicology and Applied Pharmacology. 273: 209-18. PMID 23999542 DOI: 10.1016/J.Taap.2013.08.023 | 0.704 | |||
2013 | Ngaotepprutaram T, Kaplan BL, Carney S, Crawford R, Kaminski NE. Suppression by Δ(9)-tetrahydrocannabinol of the primary immunoglobulin M response by human peripheral blood B cells is associated with impaired STAT3 activation. Toxicology. 310: 84-91. PMID 23727458 DOI: 10.1016/J.Tox.2013.05.009 | 0.675 | |||
2012 | Ngaotepprutaram T, Kaplan BL, Crawford RB, Kaminski NE. Differential modulation by delta9-tetrahydrocannabinol (∆9)-THC) of CD40 ligand (CD40L) expression in activated mouse splenic CD4+ T cells. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 7: 969-80. PMID 22851303 DOI: 10.1007/S11481-012-9390-Z | 0.696 | |||
2010 | Kaplan BL, Lawver JE, Karmaus PW, Ngaotepprutaram T, Birmingham NP, Harkema JR, Kaminski NE. The effects of targeted deletion of cannabinoid receptors CB1 and CB2 on intranasal sensitization and challenge with adjuvant-free ovalbumin. Toxicologic Pathology. 38: 382-92. PMID 20190202 DOI: 10.1177/0192623310362706 | 0.537 | |||
2009 | Lu H, Kaplan BL, Ngaotepprutaram T, Kaminski NE. Suppression of T cell costimulator ICOS by Delta9-tetrahydrocannabinol. Journal of Leukocyte Biology. 85: 322-9. PMID 18988696 DOI: 10.1189/Jlb.0608390 | 0.668 | |||
Show low-probability matches. |